New insights on hidradenitis suppurativa phenotypes and treatment response: An exploratory automated analysis of the SUNSHINE and SUNRISE trials.

J Eur Acad Dermatol Venereol · 2025 · PMC12290999 · PMID 39101698

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

SECQ2W treatment showed a trend for greater efficacy versus SECQ4W in Cluster 3 through week 52.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.